Test
For use with Clinitek 50, 100, Status Family of Urine Chemistry Analyzers
Each vial contains 100 mg of lyophilized Bovine IgG. The product was in 0.01M PBS, pH 7.4.
For Bromocresol Green reaction
For the Qualitative Detection of Albumin in Urine
Type | Exton Qualitative Reagent |
---|
BCG Albumin Assay Kit is a quantitative colorimetric albumin determination at 620 nm.
Germaine™ Laboratories MicroAlbumin 2-1 Combo Dipstick reagent strips are for the qualitative detection of Microalbumin and Creatinine
Germaine™ Laboratories AimStrip™ MACRE Strips are dipstick reagent strips for the qualitative detection of Microalbumin and Creatinine
For use with albumin test kit
Assay kit, albumin. Method: OD620nm (BCG). Samples: serum, plasma, urine, biological preparations. Species: all. Procedure: 5 min. Size: 250 tests. Detection limit: 0.01 g/dL.
Assay kit, albumin. Method: OD610nm (BCP). Samples: serum, plasma, urine, biological preparations. Species: all. Procedure: 5 min. Size: 250 tests. Detection limit: 0.3 g/dL.
The DetectX Urinary Creatinine Detection kits are designed to quantitatively measure creatinine in urine samples. A NIST calibrated creatinine standard is used to standardize the assay.
The Sovicell TRANSIL MSA Binding Kit estimates the binding of drugs to mouse serum albumin (MSA) and predicts the plasma protein binding. The assay kit measures the affinity constant (KD) of drugs to albumin and hence allows the calculation of albumin binding even under disease and physiological states that alter the albumin content of human serum. Internal quality controls provide easy assessment of recovery, experiment and data quality.
The TRANSIL Membrane Affinity kit enables researchers to measure the interaction of drugs with a membrane. This in vitro assay is designed to measure the distribution coefficient of test compounds between phosphatidylcholine membranes and an aqueous buffer. We refer to this distribution coefficient as membrane affinity.
The TRANSIL Microsomal Binding kit measures the affinity of drugs to human microsomal membranes and determines microsomal binding in stability incubation experiments. This allows the accurate estimation of intrinsic clearance from stability incubations by correcting the experimental clearance with the fraction of drug unbound in the incubation. Internal quality controls provide easy assessment of recovery, experiment and data quality.